tiprankstipranks
Pmv Pharmaceuticals, Inc. (PMVP)
NASDAQ:PMVP
US Market
PMVP
PMV Pharmaceuticals
RESEARCH TOOLSreports

PMV Pharmaceuticals (PMVP) Stock News & Sentiment

168 Followers
PMV Pharmaceuticals Advances Rezatapopt Interaction Study, Signaling Steady Progress in TP53-Driven Oncology
Premium
Company Announcements
PMV Pharmaceuticals Advances Rezatapopt Interaction Study, Signaling Steady Progress in TP53-Driven Oncology
1M ago
PMVP
Pmv Pharmaceuticals, Inc. (PMVP) Q4 Earnings Cheat Sheet
Premium
Pre-Earnings
Pmv Pharmaceuticals, Inc. (PMVP) Q4 Earnings Cheat Sheet
1M ago
PMVP
PMV Pharmaceuticals Reports Increased Quarterly Loss
Premium
Company Announcements
PMV Pharmaceuticals Reports Increased Quarterly Loss
5M ago
PMVP
Promising Developments in PMV Pharmaceuticals’ PYNNACLE Phase 2 Trial Boost Buy Rating
Premium
Ratings
Promising Developments in PMV Pharmaceuticals’ PYNNACLE Phase 2 Trial Boost Buy Rating
5M ago
PMVP
Buy Rating Affirmed for PMV Pharmaceuticals Amid Stable Financials and Strategic Growth Potential
Premium
Ratings
Buy Rating Affirmed for PMV Pharmaceuticals Amid Stable Financials and Strategic Growth Potential
5M ago
PMVP
PMV Pharmaceuticals Advances Cancer Treatment with Promising Study on PC14586
Premium
Company Announcements
PMV Pharmaceuticals Advances Cancer Treatment with Promising Study on PC14586
6M ago
PMVP
Promising Developments in PMV Pharmaceuticals’ Ovarian Cancer Treatment Drive Buy Rating
Premium
Ratings
Promising Developments in PMV Pharmaceuticals’ Ovarian Cancer Treatment Drive Buy Rating
6M ago
PMVP
More PMVP News >

PMVP News on the Web

PMV Pharmaceuticals Advances Rezatapopt Interaction Study, Signaling Steady Progress in TP53-Driven Oncology
TipRanks News
Bullish
PMV Pharma Targets Q1'27 NDA Filing For Rezatapopt In Platinum-Resistant Ovarian Cancer
rttnews
Bullish
PMV Pharma (PMVP) Reports Decline in Cash Reserves by Year-End 2025
GuruFocus News
Bearish
PMVP Reports Positive Phase 2 Results, Eyes 2027 NDA Submission
GuruFocus News
Bullish
PMV Pharmaceuticals reports FY25 EPS ($1.48), consensus ($1.51)
TipRanks News
Bullish
PMV Pharmaceuticals sees cash runway to end of 2Q27
TipRanks News
Bearish
Pmv Pharmaceuticals, Inc. (PMVP) Q4 Earnings Cheat Sheet
TipRanks News
Bullish
NEJM Publication of PMV Pharma’s Rezatapopt Data Highlights 46% Response Rate in Ovarian Cancer—What’s Next for TP53 Y220C-Mutated Tumors?
Market Chameleon
Neutral

News Score - Last 7 Days

Not enough data to generate a sentiment score
Media Buzz
This Week0 articles
Weekly Average0 articles
News Sentiment
Currently, no data available
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is PMVP’s Media Buzz Sentiment?
Currently, no data Available
What is PMVP’s weekly average amount of articles?
Currently, no data Available
What is PMVP’s News Sentiment?
Currently, no data Available
Healthcare Stocks that are Trending in the News
AORTArtivion
NBIXNeurocrine
STAAStaar Surgical
SLPSimulations Plus
OWLTOwlet
Showing the stocks with the most bullish news sentiment over the past week